[Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases].
Mitsuyama
Katsuyoshi
K
D000804:Angiotensin II / Q000502:physiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular; D006801:Humans; D007333:Insulin Resistance; D048848:MAP Kinase Kinase Kinase 5 / Q000502:physiology; D024821:Metabolic Syndrome / Q000188:drug therapy / Q000209:etiology; D018384:Oxidative Stress
D047228:Angiotensin II Type 1 Receptor Blockers; D000804:Angiotensin II; D048848:MAP Kinase Kinase Kinase 5